Personalis, Inc., a leading genomics-based service provider, today announced it is launching an expanded portfolio of cancer research solutions based on its ACE (Accuracy and Content Enhanced) sequencing, informatics and content technology platform.
Personalis and the Garvan Institute Announce Commercial Partnership for Whole Human Genome Sequencing, Analysis and Interpretation
Personalis, Inc., a leading genomics-based clinical research and diagnostics global service provider based in the USA, and the Garvan Institute of Medical Research in Sydney, Australia, today announced plans to form a commercial partnership designed to bring together best-in-class solutions for high-quality, large-scale human whole genome sequencing, analysis and interpretation for researchers and clinicians, worldwide.
Personalis, Inc., a leading genomics-based clinical diagnostic laboratory, today announced the launch of its newly enhanced ACE Clinical Exome™ Test for inherited genetic disease.
Personalis to Showcase New Products for Cancer Research and Inherited Disease Testing at ASHG Annual Meeting
Personalis, Inc., a leading genomics-based clinical diagnostic laboratory, announced it will be attending the 2014 American Society of Human Genetics Annual Meeting where it will introduce new products for cancer research and inherited disease testing. The meeting takes place October 18-22 at the San Diego Convention Center.
CAP Accreditation Is Awarded to Clinical Laboratories Meeting the Highest Standards in Quality Laboratory Practices.
Inova Translational Medicine Institute and Personalis, Inc. today announced a partnership to advance genomic medicine for Inova’s patient population. Personalis will collaborate with Inova on whole genome analysis and interpretation for undiagnosed syndromes in an effort to provide patients and their families an answer for these difficult cases.
ACE Clinical Exome™ Test Enhances Diagnostic Yield; Personalis to Present Results of 2nd Generation Augmented Exome at ACMG
Personalis, a leader in exome and genome sequencing and analysis, will discuss results of its ACE Clinical Exome test at the American College of Medical Genetics meeting this week in Nashville, TN. The ACE Clinical Exome provides the highest level of medical gene finishing available among clinical exomes by enhancing coverage of over 7,000 biomedically important genes, including additional coverage of high GC regions of the exome which are often poorly covered by other exomes.
Personalis, Inc., the leading provider of advanced medical exome and genome sequencing and interpretation services today announced that Deanna Church, Ph.D., has joined its R&D team, and Robert Nussbaum, M.D., Professor of Medicine and Chief of the Division of Genomic Medicine at UCSF, has joined its Clinical and Scientific Advisory Board.